亚洲 · 区域市场 · Vietnam Investment Review

Mabwell presents Phase II trial results for breast cancer drug 9MW2821

来源：Vietnam Investment Review · 越南 11 小时前

Biopharmaceutical firm Mabwell scheduled Phase II clinical trial data presentations for its Nectin-4-targeting antibody-drug conjugate 9MW2821 at the European Society for Medical…

在 Vietnam Investment Review 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (vir.com.vn)

Mabwell presents Phase II trial results for breast cancer drug 9MW2821

推荐阅读

Indonesia Was Finding Its Feet. Then Came MSCI

ข้อมูลในอดีตบ่งชี้ ผู้หญิงเสี่ยงตกงานจาก AI มากกว่าผู้ชาย

Jio Platforms raises ₹8,110 crore from anchor investors ahead of India's largest IPO

Jio IPO anchor book sees over 30x demand, draws record bids worth ₹2.5 trn

Mi Material focusing on ‘things that we can control’ as it launches S$215 million SGX IPO

EU officials propose guardrails for insurance risk transfer boom

Mabwell presents Phase II trial results for breast cancer drug 9MW2821

分享

推荐阅读

Indonesia Was Finding Its Feet. Then Came MSCI

ข้อมูลในอดีตบ่งชี้ ผู้หญิงเสี่ยงตกงานจาก AI มากกว่าผู้ชาย

Jio Platforms raises ₹8,110 crore from anchor investors ahead of India's largest IPO

Jio IPO anchor book sees over 30x demand, draws record bids worth ₹2.5 trn

Mi Material focusing on ‘things that we can control’ as it launches S$215 million SGX IPO

EU officials propose guardrails for insurance risk transfer boom